Dambkowski Carl

CIK 00019834762 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001983476

Recent Transactions

50 trades

Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-09-03−110,665→ 0 total
Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-09-03−124,962→ 0 total
Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-09-03−83,690→ 0 total
Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-09-03−167,123→ 0 total
Disposition to Issuer
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-09-02$135.06/sh−1,375→ 167,123 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-08-05$22.86/sh+4,125→ 173,998 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-08-05$134.17/sh−5,500→ 168,498 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-08-05−4,125→ 110,665 total
Gift
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-07-14−8,000→ 169,873 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-07-01−4,125→ 114,790 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-07-01$22.86/sh+4,125→ 183,373 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-07-01$132.74/sh−5,500→ 177,873 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-22$132.60/sh−26,400→ 179,248 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-06-12$70.11/sh−12,583→ 38,743 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-06-11$70.13/sh−22,417→ 51,326 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-06-03−4,125→ 118,915 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-03$78.71/sh−5,500→ 205,648 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-03$22.86/sh+4,125→ 211,148 total
Award
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2026-06-02+9,136→ 9,136 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Warrant (right to buy)
2026-05-21−11,904→ 10,952 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-05-21$59.97/sh−13,235→ 73,743 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-05-21$59.10/sh−53,447→ 86,978 total
Sale
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-05-21$58.43/sh−38,318→ 140,425 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2026-05-21−38,689→ 32,737 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-05-21$11.77/sh+11,667→ 178,743 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-05-21$7.80/sh+11,904→ 167,076 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-05-21$6.84/sh+38,689→ 155,172 total
Exercise/Conversion
Oruka Therapeutics, Inc.$ORKA
Stock Option (right to buy)
2026-05-21−11,667→ 5,833 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-05-06$84.60/sh−1,800→ 207,023 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-05-06$83.92/sh−3,700→ 208,823 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-05-06$22.86/sh+4,125→ 212,523 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-05-06−4,125→ 123,040 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-04-01−4,125→ 127,165 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-04-01$85.89/sh−100→ 208,398 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-04-01$85.33/sh−2,702→ 208,498 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-04-01$84.31/sh−2,698→ 211,200 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-04-01$22.86/sh+4,125→ 213,898 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-04$70.33/sh−3,225→ 212,048 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-04$22.86/sh+4,125→ 215,273 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-03-04−4,125→ 131,290 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-04$73.26/sh−200→ 209,773 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-04$71.98/sh−2,075→ 209,973 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$66.85/sh−1,299→ 211,448 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$67.88/sh−100→ 211,348 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$64.88/sh−2,481→ 214,167 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$65.83/sh−1,420→ 212,747 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$68.94/sh−200→ 211,148 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-04$22.86/sh+4,125→ 216,648 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-02-04−4,125→ 135,415 total
Other
Oruka Therapeutics, Inc.$ORKA
Common Stock
2026-01-23+116,483→ 116,483 total

Companies

Recent Filings

Address

C/O APOGEE THERAPEUTICS, INC. 1 LETTERMAN DRIVE, BUILDING B

SAN FRANCISCO, CA, 94129

View on SEC.gov